Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
暂无分享,去创建一个
J. Berzofsky | G. Leggatt | M. Alexander-Miller | J A Berzofsky | M A Alexander-Miller | G R Leggatt
[1] L. Berg,et al. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. , 1992, Journal of immunological methods.
[2] S. H. van der Burg,et al. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53 , 1993, European journal of immunology.
[3] S. Riddell,et al. Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington , 1992 .
[4] R. Zinkernagel,et al. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. , 1992, Journal of immunology.
[5] J. Berzofsky,et al. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction. , 1993, Journal of immunology.
[6] D. Jackson,et al. Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells. , 1976, The Australian journal of experimental biology and medical science.
[7] J. Rothbard,et al. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide , 1989, European journal of immunology.
[8] S. Riddell,et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.
[9] S. Rosenberg,et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. DeLisi,et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Earl,et al. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses , 1991, Journal of virology.
[12] M. Bevan,et al. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides , 1988, The Journal of experimental medicine.
[13] B. Askonas,et al. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. , 1986, Immunology.
[14] R. Zamoyska,et al. Is CD8 dependence a true reflection of TCR affinity for antigen? , 1993, International immunology.
[15] J. Bluestone,et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Yannelli. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. , 1991, Journal of immunological methods.
[17] Wallace Gd,et al. Reexamination of the efficacy of vaccination against mousepox. , 1985 .
[18] J. Connolly,et al. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes , 1991, The Journal of experimental medicine.
[19] S. Rosenberg,et al. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.
[20] P. Romero,et al. The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules , 1992, The Journal of experimental medicine.
[21] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[22] H. Clifford Lane,et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression , 1995, Nature Medicine.
[23] J. Stewart. Solid Phase Peptide Synthesis , 1984 .
[24] M. Oldstone,et al. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.
[25] J. Cerottini,et al. Antigen recognition by H‐2‐restricted cytolytic T lymphocytes: inhibition of cytolysis by anti‐CDS monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen , 1988, European journal of immunology.
[26] D. Margulies,et al. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. , 1995, Journal of immunology.
[27] R. Zinkernagel,et al. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled , 1977, The Journal of experimental medicine.